{
  "report_rows": [
    {
      "kpi": "Total Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$14.65B vs. cons $14.38B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Vyndaqel Family Revenue (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~$1.65B vs. cons $1.702B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Padcev Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$660M vs. cons $630M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Revenue (full year)",
      "prediction": "LOWER",
      "answer": "guide mid ~$61.0B vs. cons $61.76B",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY 2026 Adj. EPS (full year)",
      "prediction": "LOWER",
      "answer": "guide mid ~$2.90 vs. cons $2.94",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 0.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.0,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 implicit H2 estimate cuts pull stock lower as sell-side models are updated post-print",
  "day5_confidence": "MEDIUM"
}